Saturday, December 06, 2025 | 04:02 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Germany's Merck & Stelis Biopharma open bioprocess scale-up lab in India

Lab, based at Bengaluru, provides end-to-end solutions from bioprocess development to manufacturing

Merck’s Mobius bioreactor
premium

Merck’s Mobius bioreactor

BS B2B Bureau Bengaluru
The German science & technology company Merck, in association with Stelis Biopharma Pvt Ltd, has launched its first joint bioprocess scale-up lab in Bengaluru to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply. The lab, located at the Stelis Biopharma R&D facility in the Jigani industrial estate, was opened on May 12, 2017.

“Both Merck and Stelis bring technological expertise and an extensive bioprocess development and manufacturing portfolio that will help customers accelerate development of biopharmaceuticals for clinical trials and manufacturing with greater reliability and cost effectiveness,” said Udit Batra, member of the Merck